UP!

BIOC $4.36   View long term graphs

News

Biocept, Inc. -3.26% (healthcare)

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q4 2018 2021-03-29 0.00 0.00
Q3 2018 2018-11-13 -2.42 -2.42

Ratings

2016-06-06 Initiated Coverage Roth Capital Buy $1.20
2016-05-24 Reiterated Rating Rodman & Renshaw Buy
2016-05-13 Downgrade Feltl & Co. Strong-Buy to Buy
2016-03-31 Reiterated Rating Rodman & Renshaw Buy
2016-03-23 Reiterated Rating Rodman & Renshaw Buy $4.00
2016-03-14 Reiterated Rating Rodman & Renshaw Buy
2016-01-10 Reiterated Rating HC Wainwright Buy $4.00
2016-01-10 Reiterated Rating Rodman & Renshaw Buy
2015-08-19 Initiated Coverage HC Wainwright Buy $4.00
2015-01-21 Reiterated Rating Aegis Buy
2014-06-03 Initiated Aegis Capital Buy $16
2014-06-03 Initiated Coverage Aegis Buy $16.00
2014-05-01 Initiated Coverage Feltl & Co. Strong-Buy
2016-06-06 Initiated Coverage Roth Capital Buy $1.20
2016-05-24 Reiterated Rating Rodman & Renshaw Buy
2016-05-13 Downgrade Feltl & Co. Strong-Buy to Buy
2016-03-31 Reiterated Rating Rodman & Renshaw Buy
2016-03-23 Reiterated Rating Rodman & Renshaw Buy $4.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Funds

In BIOC 23 funds of 2210 total. Show all

Fund name Ticker shares
Vanguard Group, Inc 0.67M
BlackRock Inc. 0.19M
DRIEHAUS CAPITAL MANAGEMENT LLC 0.11M
GEODE CAPITAL MANAGEMENT, LLC 86539
BlackRock Institutional Trust Company, N.A. 56732
MORGAN STANLEY 48453
SABBY MANAGEMENT, LLC 31578
BlackRock Fund Advisors 30436
NORTHERN TRUST CORP 26459
KCG Holdings, Inc. 17372
AMERIPRISE FINANCIAL INC 15570
CITADEL ADVISORS LLC 15500
Virtu Financial LLC 14647
Creative Planning 11804
HUSSMAN STRATEGIC ADVISORS, INC. 3500

Major Shareholders

Name Relationship Total Shares Holding stocks
PITLER DAVID EVP & President BioImaging Svc 0.31%  (48800) BIOC /
STACK DAVID M 0.30%  (46500) BIOC / PCRX /

Comments